Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One power score. Smarter investment decisions
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
Markets
/
Stocks
/
nasdaq-gdtc
/
CytoMed Therapeutics Ltd
GDTC
1.865
USD
-0.015
-0.80%
Close 09/19, 16:00(ET)
Quotes delayed by 15 min
USD
0.000
After-hours (ET)
21.50M
Market Cap
--
P/E TTM
CytoMed Therapeutics Ltd
1.865
-0.015
-0.80%
Overview
Company
Financials
Analysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Analysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
FY2021H2
FY2021H1
Total equity
Cash, cash equivalents and short-term investments
-44.74%
4.97M
-38.00%
6.47M
469.41%
9.00M
601.86%
10.44M
-37.13%
1.58M
-61.83%
1.49M
--
2.51M
--
3.90M
- Cash and cash equivalents
-44.74%
4.97M
-38.00%
6.47M
469.41%
9.00M
601.86%
10.44M
-37.13%
1.58M
-61.83%
1.49M
--
2.51M
--
3.90M
Receivables
-40.80%
121.21K
-57.51%
48.84K
255.58%
204.75K
766.55%
114.94K
988.51%
57.58K
1830.71%
13.26K
--
5.29K
--
687.00
-Accounts and notes receivable
--
18.78K
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-Loans receivable
--
--
--
--
--
--
--
--
--
--
--
--
--
0.00
--
--
-Other receivables
-51.39%
99.53K
-57.51%
48.84K
255.58%
204.75K
1143.93%
114.94K
988.51%
57.58K
1244.98%
9.24K
--
5.29K
--
687.00
Inventory
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
320.85K
Prepaid expenses
4.89%
878.67K
-6.47%
835.89K
-0.39%
837.73K
30.74%
893.71K
12.37%
841.00K
12.81%
683.56K
--
748.45K
--
605.92K
Other current assets
-48.45%
30.46K
1467.53%
351.22K
279.66%
59.08K
45.94%
22.41K
2.17%
15.56K
48.12%
15.35K
--
15.23K
--
10.37K
Total current assets
-40.57%
6.00M
-32.80%
7.71M
304.86%
10.10M
421.47%
11.47M
-24.01%
2.49M
-54.50%
2.20M
--
3.28M
--
4.83M
Non-current assets
Net Fixed Assets
57.55%
3.25M
12.09%
2.48M
-16.57%
2.06M
-17.57%
2.21M
-0.83%
2.47M
26.60%
2.68M
--
2.50M
--
2.12M
-Fixed Assets
46.38%
5.02M
--
--
-2.78%
3.43M
--
--
9.10%
3.53M
32.90%
3.58M
--
3.23M
--
2.70M
-Accumulated depreciation
29.47%
1.77M
--
--
29.63%
1.36M
--
--
42.71%
1.05M
56.11%
898.01K
--
737.67K
--
575.24K
Goodwill and other intangible assets
649.62%
93.05K
-20.29%
11.01K
-34.00%
12.41K
-45.64%
13.81K
-41.26%
18.81K
-34.22%
25.41K
--
32.02K
--
38.63K
Total non-current assets
78.99%
4.07M
30.91%
3.20M
-16.87%
2.27M
-17.20%
2.45M
-2.41%
2.73M
36.83%
2.95M
--
2.80M
--
2.16M
Total assets
-18.60%
10.07M
-21.60%
10.91M
136.63%
12.37M
170.01%
13.91M
-14.06%
5.23M
-26.30%
5.15M
--
6.08M
--
6.99M
Liabilities
Current liabilities
-Other payables
-27.49%
38.70K
59.06%
29.80K
-67.57%
53.37K
-67.52%
18.74K
520.69%
164.59K
120.16%
57.70K
--
26.52K
--
26.21K
Accrued expenses
-18.57%
363.69K
29.39%
241.57K
88.31%
446.63K
103.70%
186.70K
62.49%
237.18K
-26.86%
91.66K
--
145.97K
--
125.32K
Short-term debt and lease liabilities
14.07%
45.91K
-8.73%
37.39K
-98.92%
40.25K
-98.56%
40.96K
38.44%
3.74M
10.87%
2.84M
--
2.70M
--
2.56M
-Short-term debt
--
0.00
--
--
-100.00%
0.00
-100.00%
0.00
39.10%
3.70M
11.17%
2.80M
--
2.66M
--
2.52M
-Short-term lease liabilities
30.65%
8.26K
--
--
-17.98%
6.32K
-3.86%
7.51K
-1.32%
7.71K
2.35%
7.81K
--
7.81K
--
7.63K
Deferred liabilities
1874.74%
107.74K
-21.57%
4.32K
55.71%
5.46K
-58.02%
5.50K
-74.03%
3.50K
-2.80%
13.11K
--
13.49K
--
13.49K
Other current liabilities
148.93%
146.44K
32.46%
34.12K
-65.33%
58.83K
-63.62%
25.76K
324.13%
169.69K
78.38%
70.81K
--
40.01K
--
39.70K
Total current liabilities
-15.39%
606.62K
13.67%
357.92K
-82.79%
716.94K
-89.76%
314.88K
41.84%
4.17M
9.87%
3.07M
--
2.94M
--
2.80M
Non-current liabilities
Long-term debt and lease liabilities
-3.30%
394.31K
-8.80%
390.90K
-13.02%
407.77K
-15.72%
428.61K
-13.04%
468.83K
-9.14%
508.58K
--
539.12K
--
559.71K
-Long-term debt
-3.30%
394.31K
-8.80%
390.90K
-13.02%
407.77K
-15.72%
428.61K
-13.04%
468.83K
-9.14%
508.58K
--
539.12K
--
559.71K
Total non-current liabilities
2.35%
417.34K
-9.35%
390.90K
-14.25%
407.77K
-17.01%
431.19K
-14.23%
475.54K
-10.26%
519.58K
--
554.44K
--
578.98K
Total liabilities
-8.96%
1.02M
0.37%
748.82K
-75.76%
1.12M
-79.24%
746.07K
32.94%
4.64M
6.42%
3.59M
--
3.49M
--
3.38M
Shareholders' equity
Common equity
0.00%
23.79M
0.31%
23.79M
166.96%
23.79M
208.44%
23.72M
15.90%
8.91M
0.00%
7.69M
--
7.69M
--
7.69M
Retained earnings
-19.81%
-14.77M
-29.58%
-13.42M
-50.41%
-12.33M
-70.83%
-10.36M
-61.79%
-8.20M
-50.03%
-6.06M
--
-5.07M
--
-4.04M
Capital reserves
--
--
--
0.00
--
73.93K
--
--
-100.00%
0.00
-100.00%
0.00
--
1.14M
--
2.00M
Gains losses not affecting retained earnings
75.27%
-53.76K
-9.45%
-212.01K
-70.53%
-217.40K
-184.06%
-193.70K
-311.50%
-127.48K
-100.43%
-68.19K
--
-30.98K
--
-34.02K
Non-controlling interests
8232.74%
77.75K
-33.94%
-1.10K
-40.18%
-956.00
-51.38%
-822.00
-55.35%
-682.00
-72.93%
-543.00
--
-439.00
--
-314.00
Total equity
-19.57%
9.04M
-22.84%
10.16M
1817.82%
11.24M
744.70%
13.17M
-77.38%
586.30K
-56.87%
1.56M
--
2.59M
--
3.62M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up